A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate
Clinical trial NCT02629159 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02629159
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2017-10-27
- Enrollment
- 1629
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.